Celadon Partners SPV 24 13D and 13G filings for Senti Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-20 4:05 pm Purchase | 2026-01-19 | 13D | SENTI BIOSCIENCES INC SNTI | Celadon Partners SPV 24 | 13,511,322 45.000% | 106,881 (+0.80%) | Filing |
| 2025-09-02 08:15 am Purchase | 2025-08-29 | 13D | SENTI BIOSCIENCES INC SNTI | Celadon Partners SPV 24 | 13,404,441 45.000% | 3,627,441 (+37.10%) | Filing |
| 2025-03-17 3:01 pm Unchanged | 2025-03-06 | 13D | SENTI BIOSCIENCES INC SNTI | Celadon Partners SPV 24 | 9,777,000 37.600% | 0 (Unchanged) | Filing |
| 2025-03-13 4:31 pm Purchase | 2025-03-06 | 13D | SENTI BIOSCIENCES INC SNTI | Celadon Partners SPV 24 | 9,777,000 37.600% | 9,777,000 (New Position) | Filing |